“…PDLSCs have similar features to BMMSCs and exhibit self-renewal capacity and multipotency[ 39 ]. These cells have the potential to undergo triploblastic differentiation with the ability to differentiate into not only osteoblasts, adipocytes, chondrocytes, cementoblasts, and tendon/ligament fibroblasts[ 40 , 41 ] but also myocytes[ 42 ], neural cells[ 43 ], retinal cells[ 44 ], endothelial cells[ 45 ], pancreatic islet cells[ 46 ], and hepatic cells[ 47 ]. In addition, PDLSCs express cell surface markers such as STRO-1, CD146/MUC18[ 36 ], CD44, and CD90 (markers associated with stromal cells), CD105 and CD166 (markers associated with stromal cells and endothelial cells)[ 48 ], and CD10, CD26, CD29, CD73, and CD349/FZD9[ 49 ] but do not express hematopoietic cell surface markers such as CD31 and CD45, similar to BMMSCs[ 50 ].…”